Project Grant R21AT013595
- The National Center for Complementary and Integrative Health, part of the National Institutes of Health within the Department of Health and Human Services, awarded $1,671,750 to the Regents of the University of Michigan on August 11, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to conduct a pilot trial of transcutaneous electrical accustimulation (TEA) for chronic pain management in patients with cirrhosis. The recipient will conduct the...
- The National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services National Institutes of Health, awarded Case Western Reserve University $189,000 on July 20, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). Case Western Reserve University, through its Office of Research Administration in affiliation with University Hospitals of Cleveland, will conduct a randomized, sham-controlled, parallel-group feasibility trial...
- The National Institutes of Health Office of the Director awarded Northwestern University $201,725 on August 5, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213, also known as NCCIH funding) to conduct a randomized, partially blinded proof-of-concept trial identifying brain mechanisms of placebo pill responses in chronic back pain patients. The research concentrates on chronic back pain patients with inadequate pain control who may benefit from...
- The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health under the Department of Health and Human Services, awarded the University of Maryland, Baltimore $4.929 million on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and validate a multi-omic, psychosocial, and environmental model of individual differences in pain and placebo responses. The project investigates chronic pain conditions, particularly...
- The National Center for Complementary and Integrative Health, part of the Department of Health and Human Services National Institutes of Health, awarded $398,970 to the University of Alabama at Birmingham on August 15, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award funds development of soft wearable electronic skin sensors to quantify real-time complex force dynamics during force-based manipulation and manual therapy. The soft...
- The National Center for Complementary and Integrative Health of the National Institutes of Health awarded the University of Rochester $550,030 on April 9, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to investigate the biological mechanisms linking circadian regulation of cerebrospinal fluid movement through the glymphatic and lymphatic systems to chronic neuropathic pain development. The research spans three aims: testing whether...
- The National Center for Complementary and Integrative Health awarded $831,984 to Scripps Research Institute on April 17, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to investigate the neural mechanisms by which the interoceptive system co-regulates emotional and autonomic responses. The research addresses the coupling between emotion and autonomic control—phenomena such as anxiety elevating blood pressure, stress inducing sighing, and...
- The National Center for Complementary and Integrative Health (NCCIH) awarded the University of Massachusetts Medical School a $297,373 cooperative agreement on August 17, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award funds a Data Coordinating Center (U24) to provide statistical and data management leadership for a multi-center Phase 3 randomized controlled trial (ACUITY 2) examining whether acupuncture is superior to usual care for...
- The National Center for Complementary and Integrative Health, part of the Department of Health and Human Services National Institutes of Health, awarded Duke University $444,125 on August 13, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to test the feasibility and acceptability of a psychological support and resource navigator program for orthopedic patients with high-impact chronic musculoskeletal pain. The navigator program addresses the...
- The National Center for Complementary and Integrative Health of the Department of Health and Human Services awarded Southern California University of Health Sciences $535,524 on August 15, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to assess the quality and value of non-pharmacological therapies compared to prescription drug therapy for managing spinal pain in Medicare beneficiaries aged 65 and older. The research will use Medicare...
The National Center for Complementary and Integrative Health (NCCIH), a component of the Department of Health and Human Services National Institutes of Health, awarded $407,856 to Cleveland Clinic Lerner College of Medicine of Case Western Reserve University on August 1, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The recipient will conduct research examining how alpha-frequency transcranial alternating current stimulation (tACS) targeting the dorsomedial prefrontal cortex modulates pain avoidance learning and behavior in chronic pain patients, particularly those with complex regional pain syndrome. The project employs a multimodal approach integrating behavioral measures, brain neurophysiology, and autonomic nervous system responses. Aim 1 will apply an instrumental pain avoidance task paired with computational reinforcement learning modeling to quantify tACS effects on threat and safety learning, with simultaneous magnetoencephalography recording. Aim 2 will examine both task-related and resting-state MEG activity to assess tACS effects on brain neurophysiology and autonomic responses. The research hypothesizes that enhancing alpha oscillatory power in the dorsomedial prefrontal cortex will promote adaptive pain avoidance behavior by facilitating the inhibitory processes underlying decision-making and learning. Performance occurs in Cleveland, Ohio, with an award period from August 1, 2026, through July 31, 2028. This is a Project Grant, the standard NIH research grant mechanism requiring two-stage peer review and meritorious, responsive applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $407.9k | 8/4/26 |